BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 15603182)

  • 1. Immune responses detected in urothelial carcinoma patients after vaccination with NY-ESO-1 protein plus BCG and GM-CSF.
    Sharma P; Bajorin DF; Jungbluth AA; Herr H; Old LJ; Gnjatic S
    J Immunother; 2008; 31(9):849-57. PubMed ID: 18833002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Getting melanoma cells to stimulate with frequency.
    Carson WE
    J Clin Oncol; 2005 Dec; 23(35):8929-31. PubMed ID: 16260688
    [No Abstract]   [Full Text] [Related]  

  • 3. Induction of T-cell apoptosis in rats by genetically engineered glioma cells expressing granulocyte-macrophage colony-stimulating factor and B7.1.
    Tseng SH; Chen Y; Chang CJ; Tai KF; Lin SM; Hwang LH
    Clin Cancer Res; 2005 Feb; 11(4):1639-49. PubMed ID: 15746069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combinatorial vaccine strategies and the use of molecular arrays to characterize T-cell activation.
    Schlom J; Palena C; Greiner JW; Tsang KY; Grosenbach DW; Sabzevari H; Gulley JL; Arlen PM; Kass E; Hodge JW
    Dev Biol (Basel); 2004; 116():27-47. PubMed ID: 15603182
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecularly defined vaccines for cancer immunotherapy, and protective T cell immunity.
    Speiser DE; Romero P
    Semin Immunol; 2010 Jun; 22(3):144-54. PubMed ID: 20413326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B7-1 gene-modified tumor cell vaccines.
    Antonia SJ
    Curr Opin Mol Ther; 1999 Feb; 1(1):50-6. PubMed ID: 11249684
    [No Abstract]   [Full Text] [Related]  

  • 7. Adjuvants for enhancing the immunogenicity of whole tumor cell vaccines.
    Chiang CL; Kandalaft LE; Coukos G
    Int Rev Immunol; 2011; 30(2-3):150-82. PubMed ID: 21557641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of the PANVAC-VF vaccine for pancreatic cancer.
    Petrulio CA; Kaufman HL
    Expert Rev Vaccines; 2006 Feb; 5(1):9-19. PubMed ID: 16451103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing the clinical activity of granulocyte-macrophage colony-stimulating factor-secreting tumor cell vaccines.
    Jinushi M; Hodi FS; Dranoff G
    Immunol Rev; 2008 Apr; 222():287-98. PubMed ID: 18364009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic lymphoma vaccines: importance of T-cell immunity.
    Neelapu SS; Lee ST; Qin H; Cha SC; Woo AF; Kwak LW
    Expert Rev Vaccines; 2006 Jun; 5(3):381-94. PubMed ID: 16827622
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.